Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity

In cancer immunotherapy, the use of dendritic cell (DC)-based vaccination strategies can improve overall survival, but until now durable clinical responses remain scarce. To date, DC vaccines are designed primarily to induce effective T-cell responses, ignoring the antitumor activity potential of na...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Van den Bergh, Johan, Willemen, Yannick, Lion, Eva, Van Acker, Heleen, De Reu, Hans, Anguille, Sébastien, Goossens, Herman, Berneman, Zwi, Van Tendeloo, Viggo, Smits, Evelien
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2015
Sujets:
Research Paper: Immunology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4792546/
https://ncbi.nlm.nih.gov/pubmed/26675759
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires